Shoulder Innovations Reports 65% Q1 Revenue Growth, Raises Full-Year Guidance
summarizeSummary
Shoulder Innovations, Inc. reported strong first-quarter 2026 financial results, with net revenue increasing 65% year-over-year to $16.7 million. This growth was fueled by a 51% increase in implant system sales and a 9% rise in average selling prices. Following this robust performance, the company raised its full-year 2026 net revenue guidance to a range of $65 million to $68 million, up from the previous $62 million to $65 million, now projecting 37% to 44% growth over fiscal year 2025. This positive revision to guidance, alongside the full commercial launch of its InSet™ I-135RFX Humeral Stem, signals strong operational momentum. While operating and net losses widened due to increased investments in its commercial organization and R&D, the significant revenue growth and improved outlook are material positive developments for the company.
At the time of this announcement, SI was trading at $14.42 on NYSE in the Life Sciences sector, with a market capitalization of approximately $279.4M. The 52-week trading range was $10.92 to $17.94. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.